GABA Supplements Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The GABA supplements market is on a promising growth path, projected to reach a value of $45.31 million in 2024 and $69.32 million by 2031, reflecting a CAGR of 6%. This significant expansion underscores the rising consumer awareness and demand for dietary supplements that promote relaxation, better sleep, and reduced anxiety. Capsules are expected to be the highest revenue generator in this market, with substantial growth anticipated in the coming years.

Key Drivers of Market Expansion

The primary drivers influencing the GABA supplements market include the health benefits associated with these supplements, such as providing relaxation to the brain, reducing stress levels, improving sleep quality, and decreasing anxiety and hormonal irritability. These benefits are particularly crucial in today’s fast-paced world, where mental health issues like stress, anxiety, and sleep disorders are prevalent.

According to the Sleep Foundation, a significant percentage of adults globally experience insomnia, with chronic insomnia affecting a notable portion of the population. In countries like Japan, the United States, the United Kingdom, and South Korea, a substantial number of people report dissatisfaction with their sleep quality. This widespread issue creates a significant opportunity for GABA supplements, which are known for their relaxation and sleep-enhancing properties.

Impact of COVID-19 on Mental Health

The COVID-19 pandemic has had a profound impact on mental health worldwide, with a marked increase in anxiety and depression. This surge in mental health issues has led to a greater demand for dietary supplements that promote relaxation and reduce anxiety. GABA supplements, which support neurotransmitter function, are gaining traction as effective dietary supplements to address these mental health concerns.

Premenstrual Dysphoric Disorder (PMDD) and Hypertension

Premenstrual dysphoric disorder (PMDD) is a significant issue affecting many women, causing anxiety, depression, mood swings, and irritability. GABA supplements can help alleviate these symptoms, making them an attractive option for those seeking mental wellness and reduced inflammation.

Additionally, hypertension is a growing concern globally, with a large portion of the adult population affected. Studies have shown that GABA supplements can significantly lower blood pressure, offering a potential solution for those looking to manage hypertension through dietary means.

Underlying Medical Conditions

Individuals with conditions such as Parkinson’s disease, hyperactivity disorder, and seizure disorders may have lower GABA levels in their bodies. In such cases, GABA supplements can provide additional support by producing calming effects and reducing anxiety.

Regional Growth Insights

North America

North America is a prominent market for GABA supplements, with a significant portion of the population experiencing insomnia and sleep-related issues. High levels of chronic stress and anxiety further drive the demand for GABA supplements in this region.

United States

In the United States, anxiety disorders are among the most common mental health issues, affecting millions of adults each year. Despite the availability of treatment, many individuals prefer dietary supplements to manage their anxiety, creating a growth opportunity for GABA supplements.

United Kingdom

The United Kingdom has also seen a rise in anxiety and depression, particularly in the wake of the COVID-19 pandemic. This increase has led to a higher consumption of sleeping pills and anxiety medications, highlighting the need for non-harmful alternatives like GABA supplements.

Japan

Japan faces a significant sleep disorder problem, with a large percentage of the population experiencing insomnia. This ongoing issue is driving the demand for GABA dietary supplements as a solution for better sleep and relaxation.

China

China has a high prevalence of sleep disorders, with millions of people affected. This growing problem is expected to influence the demand for dietary supplements like GABA, which promote better sleep and overall wellness.

South Korea

South Korea has notable stress and sleep-related issues, contributing to the demand for GABA supplements. The country’s focus on skincare and wellness also aligns with the benefits of GABA supplements, making them a popular choice for promoting beauty sleep and reducing stress.

Form and Competitive Analysis

GABA supplements are available in various forms, including capsules, lozenges, powder, and gummies. Capsules are projected to witness significant growth due to their convenience and efficacy.

Key players in the GABA supplements market include Now Foods, Horbaach, Pure Encapsulations, Thorne, Vitanica, Nutrabio, Country Life, Integrative Therapeutics, Solgar, and Nusa Pure. These companies offer a range of GABA supplements and provide resources such as stress-measuring tests and FAQs on their websites to help consumers choose the best products for their needs.

Segmentation of the GABA Supplements Market:

By Form:

• Capsules
• Lozenges
• Powder
• Gummies

By Distribution Channel:

• Online Stores
• Pharmacies
• Supermarkets
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

This product will be delivered within 1-3 business days.